These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30840452)

  • 1. Applications of Ensemble Docking in Potential Inhibitor Screening for Mycobacterium tuberculosis Isocitrate Lyase Using a Local Plant Database.
    Lee YV; Choi SB; Wahab HA; Lim TS; Choong YS
    J Chem Inf Model; 2019 May; 59(5):2487-2495. PubMed ID: 30840452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
    Lee YV; Wahab HA; Choong YS
    Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Site Flexibility of Mycobacterium tuberculosis Isocitrate Lyase in Dimer Form.
    Lee YV; Choi SB; Wahab HA; Choong YS
    J Chem Inf Model; 2017 Sep; 57(9):2351-2357. PubMed ID: 28820943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
    Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
    Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
    Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening.
    Ji L; Long Q; Yang D; Xie J
    Int J Biol Sci; 2011 Apr; 7(3):376-82. PubMed ID: 21494431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase.
    Tiwari A; Kumar A; Srivastava G; Sharma A
    Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
    Kwon S; Chun HL; Ha HJ; Lee SY; Park HH
    PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
    Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
    Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
    Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
    Zhou M; Xie L; Yang Z; Zhou J; Xie J
    J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth.
    May EE; Leitão A; Tropsha A; Oprea TI
    Comput Biol Chem; 2013 Dec; 47():167-80. PubMed ID: 24121675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
    Krátký M; Vinšová J
    Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
    Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
    Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.